{"product_id":"oral-controlled-release-formulation-design-and-drug-delivery-isbn-9780470253175","title":"Oral Controlled Release Formulation Design and Drug Delivery","description":"This book describes the theories, applications, and challenges for different oral controlled release formulations. This book differs from most in its focus on oral controlled release formulation design and process development. It also covers the related areas like preformulation, biopharmaceutics, in vitro-in vivo correlations (IVIVC), quality by design (QbD), and regulatory issues.  Preface.  \u003cp\u003eContributors.\u003c\/p\u003e \u003cp\u003e1 Introduction and Overview of Oral Controlled Release Formulation Design (\u003ci\u003eHong Wen and Kinam Park\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e2 Evolution of Oral Controlled Release Dosage Forms (\u003ci\u003ePing I. Lee and Jian-Xin Li\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e3 Biopharmaceutic Consideration and Assessment for Oral Controlled Release \u003cb\u003e(CR) Formulations\u003c\/b\u003e (\u003ci\u003eHua Zhang and Jean M. Surian\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e4 Preformulation Consideration for Drugs in Oral CR Formulation (\u003ci\u003eManching Sherry Ku\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e5 Polymers in Oral Modified Release Systems (\u003ci\u003eJiasheng Tu, Yan Shen, Ravichandran Mahalingam, Bhaskara Jasti, and Xiaoling Li\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e6 Oral Extended Release Hydrophilic Matrices: Formulation and Design (\u003ci\u003eXiaoguang Wen, Ali Nokhodchi, and Ali Rajabi-Siahboomi\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e7 Coating Systems for Oral Controlled Release Formulations (\u003ci\u003eLinda A. Felton\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e8 Fluid Bed Coating and Granulation for CR Delivery (\u003ci\u003eYue Teng and Zhihui Qiu\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e9 Controlled Release using Bilayer Osmotic Tablet Technology: Reducing Theory to Practice (\u003ci\u003eSheri L Shamblin\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e10 Fast Disintegrating Tablets (\u003ci\u003eSeong Hoon Jeong, Jaehwi Lee, and Jong Soo Woo\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e11 Buccal Drug Delivery Systems (\u003ci\u003eJohn D. Smart and Gemma Keegan\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e12 Oral Targeted Drug Delivery Systems: Gastric Retention Devices (\u003ci\u003eHamid Omidian and Kinam Park\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e13 Oral Targeted Drug Delivery Systems: Enteric Coating (\u003ci\u003eWendy Dulin\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e14 Orally Administered Drug Delivery Systems to the Colon (\u003ci\u003eMirela Nadler Milabuer, Yossi Kam and Abraham Rubinstein\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e15 Dissolution Testing: \u003ci\u003eIn Vitro\u003c\/i\u003e Characterization of Oral Controlled Release Dosage Forms (\u003ci\u003eMichele Xuemei Guo\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e16 Challenges and New Technologies of Oral Controlled Release (\u003ci\u003eXiaoming Chen, Hong Wen and Kinam Park\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e17 Oral Controlled Drug Delivery: Quality By Design (QbD) Approach to Drug Development (\u003ci\u003eShailesh Singh, Thirunellai G. Venkateshwaran and Stephen P. Simmons\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e18 Oral Controlled Release-Based Products for Life Cycle Management (\u003ci\u003eNipun Davar and Sangita Ghosh\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e19 Generic Oral Controlled Release Product Development: Formulation and Process Considerations (\u003ci\u003eSalah U. Ahmed and Venkatesh Naini\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e20 The Science and Regulatory Perspectives of Emerging Controlled Release Dosage Forms (\u003ci\u003eRakhi B. Shah and Mansoor A. Khan\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eIndex.\u003c\/p\u003e   \u003cbr\u003e \u003cbr\u003e  \u003cb\u003eHONG WEN, PhD,\u003c\/b\u003e is a Fellow and Project Leader in the Department of Pharmaceutical Development at Novartis, as well as a core member of the Novartis TRD S\u0026amp;T committee. He has contributed to dozens of INDs\/IMPDs in addition to several approved NDAs. His expertise spans from discovery support and preformulation to late-phase development of solid dosage forms. He also specializes in bioavailability enhancement for water insoluble drugs, oral sustained release (SR) formulations, and combination products (FDC). He has written fifteen publications, six presentations, and eight patents in the drug delivery and controlled release fields.  \u003cp\u003e\u003cb\u003eKINAM PARK, PhD,\u003c\/b\u003e is a Professor in the Department of Pharmaceutics and Showalter Distinguished Professor of Biomedical Engineering at Purdue University. He is also the President of Akina, Inc., specializing in drug delivery. Dr. Park is Editor-in-Chief of the \u003ci\u003eJournal of Controlled Release\u003c\/i\u003e among other journal and advisory board appointments. The recipient of the Controlled Release Society Founders Award in 2004, Dr. Park has published nine books, more than a hundred chapters, and more than two hundred journal articles, and holds sixteen patents.\u003c\/p\u003e  \u003cb\u003eThe comprehensive guide on the theories, applications, and challenges for oral controlled release formulations\u003c\/b\u003e  \u003cp\u003eAs the use of drugs employing oral controlled release formulations continues to grow in popularity, the pharmaceutical industry must adapt to new developments in order to select the most stable and scalable technology for achieving desired pharmacokinetic profiles.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eOral Controlled Release Formulation Design and Drug Delivery\u003c\/i\u003e is the first book of its kind to cover every aspect of oral controlled release formulations, including controlled release mechanisms, preformulation, biopharmaceutics, in vitro–in vivo correlations (IVIVC), quality by design (QbD), and regulatory affairs. Comprehensive in scope, this reference contains chapters written by some of the leading experts in the field, as well as offering additional details through a mixture of figures, tables, and references to provide information not found in similar texts. This book also discusses:\u003c\/p\u003e \u003cul\u003e \u003cli\u003e \u003cp\u003eThe theoretical and applied practical guidance for scientists in developing oral controlled release (CR) formulations\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eHow oral formulations can be made based on physico-chemical and biopharmaceutical properties of a drug\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eWhy oral controlled release formulations are a hot topic for both R\u0026amp;D and commercial delivery products\u003c\/p\u003e \u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eExtending beyond traditional coverage of oral controlled release formulations based solely on design and process development, this book covers everything a pharmaceutical practitioner or student needs to know about this exciting and progressive drug delivery field to advance medicinal benefits for patients worldwide.\u003c\/p\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":47989724872933,"sku":"NP9780470253175","price":148.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9780470253175.jpg?v=1761785258","url":"https:\/\/k12savings.com\/products\/oral-controlled-release-formulation-design-and-drug-delivery-isbn-9780470253175","provider":"K12savings","version":"1.0","type":"link"}